US Patent Application #20040186522 "Apparatus for pericardial augmentation" The proposed hypothesis is based on theory positing the right and left ventricles incur pathologic autonomic electrical ischemia proportional to the degree that pathologic blood perfusion ischemia incurs negative global cardiac performance. Many methods have been pursued to address hematologic ischemia within the myocardium. Modeling of autonomic electrical perfusion appears to follow the same branches of the vascular tree within the myocardium. Novelty of the intervention: Theory allows a selectively targeted computational method to electrically depolarize the ventricles from an "outside in" or external perspective rather than known art claiming "inside out" or internal depolarization derived from internally/endovascular blood exposed cardiac devices. Essential point: A computationally targeted electrical web within the pericardial space may reach marginally viable myocardium refractory to restoration of blood perfusion.

6/15/21 This application for an external pacemaker remains mired in legal challenges beyond my means but apparently still stands unchallenged.§ 12/3/22 Technology applying external "outside in" pacing from the epicardium/pericardial space remains unknown to Wikipedia.

4/6/23 Today the application is widely documented as US20040186522A1 including "Legal Events" 2006-09-14 Code STCB Title "Information on status:Application Discontinuation". I spent the last check I could and got a letter back from the Government stating "Abandoned-Failure to respond to an office action". I regret this approach would require large animal testing. 5/18/24 Selective pacing from the epicardial surface towards an otherwise nonviable region of the myocardium is a novel approach that may reach both microvascular and electrical ischemia.